Back to Susquehanna International Group, LLP Susquehanna International Group, LLP

MDGLMDGL

Showing 8 of 31 quarters

Position history for Susquehanna International Group, LLPSusquehanna International Group, LLP's holdings in Madrigal Pharmaceuticals, Inc.

Yes. Susquehanna International Group holds 148,610 shares of MDGL, worth $79.8M, as of its Q2 2026 13F filing. It increased the position from 22,216 shares in Q1 2026. Susquehanna International Group has held MDGL since Q3 2022, across 16 quarterly 13F filings.

Current Value

$79.8M

Current Shares

148,610

Total Value Change

+$75.9M

Total Shares Change

+130,403

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
148,610
+568.9%
$79.8M0.0%$536.95
48
2026-Q1
Decreased
22,216
-65.5%
$11.6M0.0%$523.47
0
2025-Q4
Decreased
64,466
-38.5%
$37.5M0.0%$582.34
0
2025-Q3
Increased
104,818
+4.5%
$48.1M0.0%$458.66
31
2025-Q2
Decreased
100,322
-29.7%
$30.4M0.0%$302.64
0
2025-Q1
Increased
142,643
+773.9%
$47.2M0.0%$331.23
47
2024-Q4
Decreased
16,323
-10.3%
$5M0.0%$308.57
0
2024-Q3
Increased
18,207
+278.2%
$3.9M0.0%$212.22
43

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used